• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构计算免疫原性分析 L-门冬酰胺酶从.

A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from .

机构信息

Laboratory of Natural Products, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

inSiliTox, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

出版信息

Int J Mol Sci. 2024 Apr 27;25(9):4788. doi: 10.3390/ijms25094788.

DOI:10.3390/ijms25094788
PMID:38732010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11084778/
Abstract

L-asparaginase is an essential drug used to treat acute lymphoid leukemia (ALL), a cancer of high prevalence in children. Several adverse reactions associated with L-asparaginase have been observed, mainly caused by immunogenicity and allergenicity. Some strategies have been adopted, such as searching for new microorganisms that produce the enzyme and applying protein engineering. Therefore, this work aimed to elucidate the molecular structure and predict the immunogenic profile of L-asparaginase from , recently revealed as a new fungus of the genus and producer of the enzyme, as a motivation to search for alternatives to bacterial L-asparaginase. In the evolutionary relationship, L-asparaginase from closely matches species. Using in silico tools, we characterized the enzyme as a protein fragment of 378 amino acids (39 kDa), including a signal peptide containing 17 amino acids, and the isoelectric point at 5.13. The oligomeric state was predicted to be a homotetramer. Also, this L-asparaginase presented a similar immunogenicity response (T- and B-cell epitopes) compared to and enzymes. These results suggest a potentially useful L-asparaginase, with insights that can drive strategies to improve enzyme production.

摘要

L-天冬酰胺酶是一种用于治疗急性淋巴细胞白血病(ALL)的重要药物,ALL 是一种在儿童中高发的癌症。已经观察到与 L-天冬酰胺酶相关的几种不良反应,主要是由免疫原性和变应原性引起的。已经采取了一些策略,例如寻找产生该酶的新微生物,并应用蛋白质工程。因此,这项工作旨在阐明 L-天冬酰胺酶的分子结构,并预测最近被揭示为新真菌属和该酶生产者的 的免疫原性特征,以寻找替代细菌 L-天冬酰胺酶的方法。在进化关系中, 中的 L-天冬酰胺酶与 种密切匹配。我们使用计算工具将该酶表征为 378 个氨基酸(39 kDa)的蛋白质片段,包括含有 17 个氨基酸的信号肽,等电点为 5.13。预测寡聚状态为同源四聚体。此外,与 和 酶相比,这种 L-天冬酰胺酶表现出相似的免疫原性反应(T 细胞和 B 细胞表位)。这些结果表明,这种 L-天冬酰胺酶具有潜在的用途,并为提高酶产量的策略提供了思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/6f3fc09bf32d/ijms-25-04788-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/66e7f4ba5547/ijms-25-04788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/af1ee31a1904/ijms-25-04788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/6fbb64757c70/ijms-25-04788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/198e1702828b/ijms-25-04788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/6ae6137445a0/ijms-25-04788-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/fd9b89efb7ac/ijms-25-04788-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/a48deb78533f/ijms-25-04788-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/102845175ec3/ijms-25-04788-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/100f6b24467f/ijms-25-04788-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/03d5932651dc/ijms-25-04788-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/aa973fb8e5c3/ijms-25-04788-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/6f3fc09bf32d/ijms-25-04788-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/66e7f4ba5547/ijms-25-04788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/af1ee31a1904/ijms-25-04788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/6fbb64757c70/ijms-25-04788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/198e1702828b/ijms-25-04788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/6ae6137445a0/ijms-25-04788-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/fd9b89efb7ac/ijms-25-04788-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/a48deb78533f/ijms-25-04788-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/102845175ec3/ijms-25-04788-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/100f6b24467f/ijms-25-04788-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/03d5932651dc/ijms-25-04788-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/aa973fb8e5c3/ijms-25-04788-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ab/11084778/6f3fc09bf32d/ijms-25-04788-g012.jpg

相似文献

1
A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from .结构计算免疫原性分析 L-门冬酰胺酶从.
Int J Mol Sci. 2024 Apr 27;25(9):4788. doi: 10.3390/ijms25094788.
2
Decreasing the immunogenicity of Erwinia chrysanthemi asparaginase via protein engineering: computational approach.通过蛋白质工程降低欧文氏菌天冬酰胺酶的免疫原性:计算方法。
Mol Biol Rep. 2019 Oct;46(5):4751-4761. doi: 10.1007/s11033-019-04921-5. Epub 2019 Jul 9.
3
In silico identification and characterization of antineoplastic asparaginase enzyme from endophytic bacteria.内生细菌抗肿瘤天冬酰胺酶的计算机模拟鉴定与表征
IUBMB Life. 2020 May;72(5):991-1000. doi: 10.1002/iub.2237. Epub 2020 Jan 25.
4
Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.根瘤农杆菌 asparaginase II:急性淋巴细胞白血病(ALL)治疗的一种选择。
Bioengineered. 2013 Jan-Feb;4(1):30-6. doi: 10.4161/bioe.21710. Epub 2012 Aug 16.
5
Studies on Deimmunization of Antileukaemic L-Asparaginase to have Reduced Clinical Immunogenicity--An in silico Approach.降低临床免疫原性的抗白血病L-天冬酰胺酶去免疫研究——一种计算机模拟方法
Pathol Oncol Res. 2015 Sep;21(4):909-20. doi: 10.1007/s12253-015-9912-0. Epub 2015 Mar 6.
6
A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora.大肠杆菌和胡萝卜软腐欧文氏菌天冬酰胺酶免疫原性的计算机结构分析
Biologicals. 2019 May;59:47-55. doi: 10.1016/j.biologicals.2019.03.003. Epub 2019 Mar 11.
7
Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.不同细菌L-天冬酰胺酶表位的免疫原性比较及结构分析
BMC Cancer. 2016 Feb 11;16:89. doi: 10.1186/s12885-016-2125-4.
8
Mapping of B-cell epitopes in E. coli asparaginase II, an enzyme used in leukemia treatment.大肠杆菌天冬酰胺酶II(一种用于白血病治疗的酶)中B细胞表位的定位
Biol Chem. 2005 Jun;386(6):535-40. doi: 10.1515/BC.2005.063.
9
In vitro screening and in silico validation revealed key microbes for higher production of significant therapeutic enzyme l-asparaginase.体外筛选和计算机模拟验证揭示了用于高效生产重要治疗性酶L-天冬酰胺酶的关键微生物。
Enzyme Microb Technol. 2017 Mar;98:9-17. doi: 10.1016/j.enzmictec.2016.12.001. Epub 2016 Dec 9.
10
A potential type-II L-asparaginase from marine isolate Bacillus australimaris NJB19: Statistical optimization, in silico analysis and structural modeling.一株海洋来源的南极芽胞杆菌潜在的 II 型 L-天冬酰胺酶:统计优化、计算机分析和结构建模。
Int J Biol Macromol. 2021 Mar 31;174:527-539. doi: 10.1016/j.ijbiomac.2021.01.130. Epub 2021 Jan 25.

引用本文的文献

1
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI.靶向肿瘤微环境中代谢途径的纳米药物:未来展望与人工智能的作用
Metabolites. 2025 Mar 13;15(3):201. doi: 10.3390/metabo15030201.
2
Enhancing the Stability and Anticancer Activity of Asparaginase Through Nanoparticle Immobilization: A Biotechnological Perspective on Nano Chitosan.通过纳米颗粒固定化提高天冬酰胺酶的稳定性和抗癌活性:纳米壳聚糖的生物技术视角
Polymers (Basel). 2024 Nov 23;16(23):3260. doi: 10.3390/polym16233260.

本文引用的文献

1
BepiPred-3.0: Improved B-cell epitope prediction using protein language models.BepiPred-3.0:使用蛋白质语言模型改进 B 细胞表位预测。
Protein Sci. 2022 Dec;31(12):e4497. doi: 10.1002/pro.4497.
2
L-Asparaginase from Produced by a Recombinant Strain.由重组菌株产生的L-天冬酰胺酶。
Pharmaceuticals (Basel). 2022 Jun 14;15(6):746. doi: 10.3390/ph15060746.
3
Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy.关于使用L-天冬酰胺酶作为一种高效且安全的抗癌疗法的新见解。
Cancers (Basel). 2022 Feb 11;14(4):902. doi: 10.3390/cancers14040902.
4
AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models.AlphaFold 蛋白质结构数据库:用高精度模型极大地扩展蛋白质序列空间的结构覆盖范围。
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444. doi: 10.1093/nar/gkab1061.
5
Sequencing and characterization of an L-asparaginase gene from a new species of Penicillium section Citrina isolated from Cerrado.从塞拉多中分离出的新种青霉属 Citrina 中 L-天冬酰胺酶基因的测序和特性分析。
Sci Rep. 2021 Sep 9;11(1):17861. doi: 10.1038/s41598-021-97316-1.
6
Filamentous Fungi Producing l-Asparaginase with Low Glutaminase Activity Isolated from Brazilian Savanna Soil.从巴西稀树草原土壤中分离出具有低谷氨酰胺酶活性的产L-天冬酰胺酶丝状真菌。
Pharmaceutics. 2021 Aug 17;13(8):1268. doi: 10.3390/pharmaceutics13081268.
7
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
8
L-asparaginase production review: bioprocess design and biochemical characteristics.L-天冬酰胺酶生产综述:生物工艺设计与生化特性。
Appl Microbiol Biotechnol. 2021 Jun;105(11):4515-4534. doi: 10.1007/s00253-021-11359-y. Epub 2021 Jun 1.
9
Structural and functional diversity of asparaginases: Overview and recommendations for a revised nomenclature.天冬酰胺酶的结构和功能多样性:概述及修订命名法的建议。
Biotechnol Appl Biochem. 2022 Apr;69(2):503-513. doi: 10.1002/bab.2127. Epub 2021 Mar 19.
10
Generalized enzymatic mechanism of catalysis by tetrameric L-asparaginases from mesophilic bacteria.嗜温细菌四聚天冬酰胺酶的催化的广义酶促机制。
Sci Rep. 2020 Oct 15;10(1):17516. doi: 10.1038/s41598-020-74480-4.